BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilbertson-White S, Perkhounkova Y, Saeidzadeh S, Hein M, Dahl R, Simons-Burnett A. Understanding Symptom Burden in Patients With Advanced Cancer Living in Rural Areas. Oncol Nurs Forum 2019;46:428-41. [PMID: 31225835 DOI: 10.1188/19.ONF.428-441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kamalumpundi V, Saeidzadeh S, Chi NC, Nair R, Gilbertson-White S. The efficacy of web or mobile-based interventions to alleviate emotional symptoms in people with advanced cancer: a systematic review and meta-analysis. Support Care Cancer 2021. [PMID: 34735601 DOI: 10.1007/s00520-021-06496-z] [Reference Citation Analysis]
2 Bian T, Zheng M, Jiang D, Liu J, Sun H, Li X, Liu L, Zhang J, Liu Y. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Cancer Cell Int 2021;21:144. [PMID: 33653340 DOI: 10.1186/s12935-021-01849-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ulrich CM, Knafl K, Foxwell AM, Zhou Q, Paidipati C, Tiller D, Ratcliffe SJ, Wallen GR, Richmond TS, Naylor M, Gordon TF, Grady C, Miller V. Experiences of Patients After Withdrawal From Cancer Clinical Trials. JAMA Netw Open 2021;4:e2120052. [PMID: 34374772 DOI: 10.1001/jamanetworkopen.2021.20052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Watson L, Qi S, Photitai E, DeIure A. A Cross-Sectional Analysis of Ambulatory Oncology Experience by Treatment Intent. Curr Oncol 2020;28:98-106. [PMID: 33704180 DOI: 10.3390/curroncol28010013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Albahde MAH, Zhang P, Zhang Q, Li G, Wang W. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle. Front Oncol 2020;10:49. [PMID: 32117719 DOI: 10.3389/fonc.2020.00049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]